| Literature DB >> 34618224 |
Paolo Preziosa1,2, Lorenzo Conti1, Maria A Rocca1,2,3, Massimo Filippi4,5,6,7,8.
Abstract
In this review, we critically summarize recent findings derived from randomized controlled trials (RCTs), observational studies and meta-analyses that have been published in the last 3 years and that included the effects of DMTs on cognitive performances among their outcomes.Entities:
Keywords: Cognition; Disease modifying drugs; Multiple sclerosis
Mesh:
Year: 2021 PMID: 34618224 DOI: 10.1007/s00415-021-10832-y
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849